Benefits of moving to SaaS and the Cloud

To improve agility and scalability, life sciences companies are embracing Software as a Service (SaaS) as part of their IT strategy.

If you aren’t familiar with SaaS, it enables users to access software applications that are based in the cloud. Third party vendors host SaaS applications on their servers and provide access over the Internet. Pharmaceutical and medical device companies have traditionally had concerns about moving to SaaS solutions (effort, security, compliance, etc.), but with advancements in technologies and services, vendors have addressed those concerns.

Nonetheless, you may have questions about whether a SaaS solution is right for your organization. The table below shows some of the pros and cons to consider when making your decision.

When it comes to cost and effort to deploy, access, and maintain applications, SaaS offers more than traditional in-house legacy applications. When planning for your organization’s software needs, you’ll benefit from making SaaS a part of your IT improvement and growth strategies.

Previous
Previous

Validation Killed the GxP Star

Next
Next

eConsent: For More Successful Clinical Trials